Assesment of Multiomics Profiles in Health and Disease. (ENIGMA)

The Institute of Molecular and Translational Medicine, Czech Republic

Status: Enrolling

Conditions: Genetic Predisposition to Disease

Treatments: Other: Race and ethnicity; Other: Health status; Genetic: Blood sample analysis

Study type: Observational

Funder types: Other

Identifiers

NCT04427163

302

Details and patient eligibility

About

This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population and will evaluate its correlation with the disease phenotype.

Full description

This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population. Initially, there will be 1000 healthy volunteers, with the planned expansion to 10.000 participants (healthy volunteers and patients with different types of disease). Formation of the reference database of healthy volunteers and their parameters will allow a correct interpretation of the potential pathological findings in patients. It is very important to obtain healthy controls from the region of the Czech Republic, Central Europe respectively; since it is not possible to reliably compere ethnically and geographically diverse populations, which have generated in a different context and where the diseases manifest with other etiology ad phenotype. Although, in the limited measure, the similar molecular data exist in foreign databases, these are not compiled from the inhabitants of the Czech Republic, Central Europe not even from Slavic population. Study participants may volunteer for archiving of remaining biological materials for future studies.

Enrollment: 1,100 estimated patients

Sex: All

Ages: 18 to 68 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age 18 - 68 years
• (for the first 1100 subjects):
• healthy volunteers without genetically dependent disease and without such a disease in a family
• healthy volunteer without the preliminary evidence of civilizational diseases such as hypertension, diabetes, autoimmune and tumor diseases or acute infectional diseases; clinically manifesting cardiovascular or pulmonary disability.
• subject without permanent of long-term medication in the time of biological sampling.

Exclusion criteria

• not complying with inclusion criteria

Trial design

1,100 participants in 1 patient group

Genomic, transcriptomic, proteomic, metabolomic profiles

Description:

Determination of genomic, transcriptomic, proteomic, metabolomic profiles in subjects.

Treatment:

Genetic: Blood sample analysis

Other: Race and ethnicity

Other: Health status